The Milbrandt Lab published a paper recently in Glia. The paper, “Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy,” shows that Schwann cells┬ámay play an important role in diabetic neuropathy and targeting their metabolism could lead to new therapies for diabetic neuropathy. Amber Hackett, a postdoc in the Milbrandt Lab, is first author on the paper. Amy Strickland, a lab manager in the Milbrandt Lab, is also an author on the paper. Jeff Milbrandt, M.D., Ph.D., the James S. McDonnell Professor of Genetics and head of the Department of Genetics, is senior author on the paper. Congratulations, all!